Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Cerestar Indonesia Tbk. (TRGU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Cerestar Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Cerestar Indonesia Tbk. trades at Rp165 (market cap 1.29T, 196.6K 24h volume). The key difference: Cerestar Indonesia Tbk. is far larger — about 4.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 196.6K). Which is the better fit depends on your goals.
| DGNS | TRGU | |
|---|---|---|
Market Cap | 310.75B | 1.29T |
Volume | 963.6K | 196.6K |
Lot | 9.64K | 1.97K |
Turnover | 217.67M | 31.18M |
Average Price | 225.89 | 158.59 |
Value | 217.67M | 31.18M |
Indicative Equilibrium Price | 226 | 165 |
Indicative Equilibrium Volume | 1K | 65 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Cerestar Indonesia Tbk.
PT. Cerestar Indonesia Tbk (the Company) was established based on Notarial Deed No. 2 datedAugust 30, 2020 of Dwi Yulianti, S.H., notary in Jakarta The Company started its commercial operations in 2021.
Read more on TRGU →
